Literature DB >> 27861908

Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.

Inés Álvarez-Miguel1, Pilar Cidad1, M Teresa Pérez-García1, José Ramón López-López1.   

Abstract

KEY POINTS: Canonical transient receptor potential (TRPC)3 and TRPC6 channels of vascular smooth muscle cells (VSMCs) mediate stretch- or agonist-induced cationic fluxes, contributing to membrane potential and vascular tone. Native TRPC3/C6 channels can form homo- or heterotetrameric complexes, which can hinder individual TRPC channel properties. The possibility that the differences in their association pattern may change their contribution to vascular tone in hypertension is unexplored. Functional characterization of heterologously expressed channels showed that TRPC6-containing complexes exhibited Pyr3/Pyr10-sensitive currents, whereas TRPC3-mediated currents were blocked by anti-TRPC3 antibodies. VSMCs from hypertensive (blood pressure high; BPH) mice have larger cationic basal currents insensitive to Pyr10 and sensitive to anti-TRPC3 antibodies. Consistently, myography studies showed a larger Pyr3/10-induced vasodilatation in BPN (blood pressure normal) mesenteric arteries. We conclude that the increased TRPC3 channel expression in BPH VSMCs leads to changes in TRPC3/C6 heteromultimeric assembly, with a higher TRPC3 channel contribution favouring depolarization of hypertensive VSMCs. ABSTRACT: Increased vascular tone in essential hypertension involves a sustained rise in total peripheral resistance. A model has been proposed in which the combination of membrane depolarization and higher L-type Ca2+ channel activity generates augmented Ca2+ influx into vascular smooth muscle cells (VSMCs), contraction and vasoconstriction. The search for culprit ion channels responsible for membrane depolarization has provided several candidates, including members of the canonical transient receptor potential (TRPC) family. TRPC3 and TRPC6 are diacylglycerol-activated, non-selective cationic channels contributing to stretch- or agonist-induced depolarization. Conflicting information exists regarding changes in TRPC3/TRPC6 functional expression in hypertension. However, although TRPC3-TRPC6 channels can heteromultimerize, the possibility that differences in their association pattern may change their functional contribution to vascular tone is largely unexplored. We probe this hypothesis using a model of essential hypertension (BPH mice; blood pressure high) and its normotensive control (BPN mice; blood pressure normal). First, non-selective cationic currents through homo- and heterotetramers recorded from transfected Chinese hamster ovary cells indicated that TRPC currents were sensitive to the selective antagonist Pyr10 only when TRPC6 was present, whereas intracellular anti-TRPC3 antibody selectively blocked TRPC3-mediated currents. In mesenteric VSMCs, basal and agonist-induced currents were more sensitive to Pyr3 and Pyr10 in BPN cells. Consistently, myography studies showed a larger Pyr3/10-induced vasodilatation in BPN mesenteric arteries. mRNA and protein expression data supported changes in TRPC3 and TRPC6 proportions and assembly, with a higher TRPC3 channel contribution in BPH VSMCs that could favour cell depolarization. These differences in functional and pharmacological properties of TRPC3 and TRPC6 channels, depending on their assembly, could represent novel therapeutical opportunities.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Keywords:  TRP channels; essential hypertension; vascular smooth muscle

Mesh:

Substances:

Year:  2016        PMID: 27861908      PMCID: PMC5330869          DOI: 10.1113/JP273327

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity.

Authors:  Sevvandi Senadheera; Youngsoo Kim; T Hilton Grayson; Sianne Toemoe; Mikhail Y Kochukov; Joel Abramowitz; Gary D Housley; Rebecca L Bertrand; Preet S Chadha; Paul P Bertrand; Timothy V Murphy; Marianne Tare; Lutz Birnbaumer; Sean P Marrelli; Shaun L Sandow
Journal:  Cardiovasc Res       Date:  2012-06-21       Impact factor: 10.787

3.  A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.

Authors:  Sarah Koenig; Michaela Schernthaner; Heinrich Maechler; C Oliver Kappe; Toma N Glasnov; Gerald Hoefler; Marlen Braune; Eric Wittchow; Klaus Groschner
Journal:  J Pharmacol Exp Ther       Date:  2012-09-25       Impact factor: 4.030

Review 4.  Signal transduction pathways and gating mechanisms of native TRP-like cation channels in vascular myocytes.

Authors:  A P Albert; W A Large
Journal:  J Physiol       Date:  2005-09-29       Impact factor: 5.182

5.  De novo expression of Kv6.3 contributes to changes in vascular smooth muscle cell excitability in a hypertensive mice strain.

Authors:  Alejandro Moreno-Domínguez; Pilar Cidad; Eduardo Miguel-Velado; José R López-López; M Teresa Pérez-García
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

6.  Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction.

Authors:  Michael Mederos y Schnitzler; Ursula Storch; Simone Meibers; Pascal Nurwakagari; Andreas Breit; Kirill Essin; Maik Gollasch; Thomas Gudermann
Journal:  EMBO J       Date:  2008-11-06       Impact factor: 11.598

7.  TRPC3 channel confers cerebrovascular remodelling during hypertension via transactivation of EGF receptor signalling.

Authors:  Mi Wang; Yong-Bo Tang; Ming-Ming Ma; Jing-Hui Chen; Chang-Ping Hu; Shui-Ping Zhao; Dao-Quan Peng; Jia-Guo Zhou; Yong-Yuan Guan; Zheng Zhang
Journal:  Cardiovasc Res       Date:  2015-11-23       Impact factor: 10.787

8.  Upregulated TRPC3 and Downregulated TRPC1 Channel Expression during Hypertension is Associated with Increased Vascular Contractility in Rat.

Authors:  Muzamil M Z Noorani; Rebecca C Noel; Sean P Marrelli
Journal:  Front Physiol       Date:  2011-07-22       Impact factor: 4.566

9.  TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.

Authors:  Kathryn Quick; Jing Zhao; Niels Eijkelkamp; John E Linley; Francois Rugiero; James J Cox; Ramin Raouf; Martine Gringhuis; Jane E Sexton; Joel Abramowitz; Ruth Taylor; Andy Forge; Jonathan Ashmore; Nerissa Kirkwood; Corné J Kros; Guy P Richardson; Marc Freichel; Veit Flockerzi; Lutz Birnbaumer; John N Wood
Journal:  Open Biol       Date:  2012-05       Impact factor: 6.411

10.  Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways.

Authors:  H Schleifer; B Doleschal; M Lichtenegger; R Oppenrieder; I Derler; I Frischauf; T N Glasnov; C O Kappe; C Romanin; K Groschner
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 9.473

View more
  12 in total

1.  Structure-function analyses of the ion channel TRPC3 reveal that its cytoplasmic domain allosterically modulates channel gating.

Authors:  Francisco Sierra-Valdez; Caleigh M Azumaya; Luis O Romero; Terunaga Nakagawa; Julio F Cordero-Morales
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

2.  TRPC6, a therapeutic target for pulmonary hypertension.

Authors:  Pritesh P Jain; Ning Lai; Mingmei Xiong; Jiyuan Chen; Aleksandra Babicheva; Tengteng Zhao; Sophia Parmisano; Manjia Zhao; Cole Paquin; Moreen Matti; Ryan Powers; Angela Balistrieri; Nick H Kim; Daniela Valdez-Jasso; Patricia A Thistlethwaite; John Y-J Shyy; Jian Wang; Joe G N Garcia; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-27       Impact factor: 6.011

Review 3.  Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.

Authors:  Yuan-Yuan Gao; Wen Tian; Hui-Nan Zhang; Yang Sun; Jing-Ru Meng; Wei Cao; Xiao-Qiang Li
Journal:  Arch Pharm Res       Date:  2021-03-24       Impact factor: 4.946

Review 4.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

Review 5.  Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.

Authors:  Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

6.  Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-β1/Smad2/3 Induces Atrial Fibrosis in Aging and Spontaneously Hypertensive Rats.

Authors:  Rongfang He; Juan Zhang; Dan Luo; Yiyan Yu; Tangting Chen; Yan Yang; Fengxu Yu; Miaoling Li
Journal:  Oxid Med Cell Longev       Date:  2019-11-23       Impact factor: 6.543

Review 7.  Role of store-operated Ca2+ entry in cardiovascular disease.

Authors:  Ting Lu; Yihua Zhang; Yong Su; Dayan Zhou; Qiang Xu
Journal:  Cell Commun Signal       Date:  2022-03-18       Impact factor: 5.712

8.  Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.

Authors:  Yu Zhao; Li Li; Zongshi Lu; Yingru Hu; Hexuan Zhang; Fang Sun; Qiang Li; Chengkang He; Wentao Shu; Lijuan Wang; Tingbing Cao; Zhidan Luo; Zhencheng Yan; Daoyan Liu; Peng Gao; Zhiming Zhu
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

Review 9.  TRPC and TRPV Channels' Role in Vascular Remodeling and Disease.

Authors:  Marta Martín-Bórnez; Isabel Galeano-Otero; Raquel Del Toro; Tarik Smani
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

Review 10.  Transient Receptor Potential Canonical (TRPC) Channels: Then and Now.

Authors:  Xingjuan Chen; Gagandeep Sooch; Isaac S Demaree; Fletcher A White; Alexander G Obukhov
Journal:  Cells       Date:  2020-08-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.